Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Noémi, Nyolczas"'
Autor:
Balázs Solymossi, Balázs Muk, Róbert Sepp, Tamás Habon, Attila Borbély, Krisztina Heltai, Zsuzsanna Majoros, Zoltán Járai, Dénes Vágány, Ákos Szatmári, Erzsébet Sziliczei, Fanni Bánfi‐Bacsárdi, Noémi Nyolczas
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 783-794 (2024)
Abstract Aims The aim of the study was to assess the incidence and predictive factors of the development of heart failure with improved ejection fraction (HFimpEF) category during a 1 year follow‐up period in a heart failure with reduced ejection f
Externí odkaz:
https://doaj.org/article/390d534829ba4d03a7f5916c0194032f
Autor:
Balázs Muk, Fanni Bánfi-Bacsárdi, Máté Vámos, Dávid Pilecky, Zsuzsanna Majoros, Gábor Márton Török, Dénes Vágány, Balázs Polgár, Balázs Solymossi, Tünde Dóra Borsányi, Péter Andréka, Gábor Zoltán Duray, Róbert Gábor Kiss, Miklós Dékány, Noémi Nyolczas
Publikováno v:
Diagnostics, Vol 14, Iss 2, p 131 (2024)
(1) Background: Besides the use of guideline-directed medical therapy (GDMT), multidisciplinary heart failure (HF) outpatient care (HFOC) is of strategic importance in HFrEF. (2) Methods: Data from 257 hospitalised HFrEF patients between 2019 and 202
Externí odkaz:
https://doaj.org/article/71c90daae70b4c0faab0c86e43df4db4
Autor:
Anita Zadori, Zsuzsanna Kis, Tibor Toth, Matyas Szigeti, Andras Temesvari, Geza Fontos, Noémi Nyolczas, Peter Andreka
Publikováno v:
International Heart Journal. 64:188-195
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::803c02ed681fa8d92e8ea6201bd4cb68
https://doi.org/10.1536/ihj.22-639
https://doi.org/10.1536/ihj.22-639
Autor:
Róbert Sepp, Lidia Hategan, Beáta Csányi, János Borbás, Annamária Tringer, Eszter Dalma Pálinkás, Viktória Nagy, Hedvig Takács, Dóra Latinovics, Noémi Nyolczas, Attila Pálinkás, Réka Faludi, Miklós Rábai, Gábor Tamás Szabó, Dániel Czuriga, László Balogh, Róbert Halmosi, Attila Borbély, Tamás Habon, Zoltán Hegedűs, István Nagy
Publikováno v:
Diagnostics, Vol 12, Iss 5, p 1132 (2022)
Hypertrophic cardiomyopathy (HCM) is a primary disease of the myocardium most commonly caused by mutations in sarcomeric genes. We aimed to perform a nationwide large-scale genetic analysis of a previously unreported, representative HCM cohort in Hun
Externí odkaz:
https://doaj.org/article/6362fa260e40429f98fc1d13dc6de1c2
Autor:
Fanni Bánfi-Bacsárdi, Balázs Muk, Dávid Pilecky, Gábor Zoltán Duray, Róbert Gábor Kiss, Noémi Nyolczas
Publikováno v:
Cardiology. 148:27-37
Introduction: Hospitalization due to heart failure (HF) progression is associated with poor prognosis. This highlights the role of the implementation of guideline-directed medical therapy (GDMT) in improving the morbidity and mortality of patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecb05aab5e455414b73b9f0d7a7a16d0
https://doi.org/10.1159/000528505
https://doi.org/10.1159/000528505
Autor:
Guntram Schernthaner, Chaim Lotan, Elina Baltadzhieva-Trendafilova, Jonas Ceponis, Martin Clodi, Kristine Ducena, Eva Goncalvesova, Cristian Guja, Marek Honka, Andrej Janež, Nebojša Lalić, Roger Lehmann, Noémi Nyolczas, Priit Pauklin, Andrzej Rynkiewicz, Igor Sergienko, Lea Smirčić Duvnjak
Publikováno v:
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-6 (2018)
Abstract Cardiovascular disease (CVD) is the most significant prognostic factor in individuals with type 2 diabetes (T2D). However, a significant number of individuals may develop CVD that does not present with the classic angina-related or heart fai
Externí odkaz:
https://doaj.org/article/f7662e14a56f43069b7ffbdcfeadece8
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0207269 (2018)
AimsLeft ventricular ejection fraction (LVEF) is the most frequently used parameter in the assessment of heart failure (HF). Cardiac index (CI) is considered a potential alternative to LVEF despite limited evidence. We aimed to assess and compare the
Externí odkaz:
https://doaj.org/article/027e3d5382404c4886e2f34fb10f23b8
Autor:
Noémi Nyolczas
Publikováno v:
Hypertonia és Nephrologia. 24:14-20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6493ea1bec2e80b0e06b5433519298c0
https://doi.org/10.33668/hn.24.002
https://doi.org/10.33668/hn.24.002
Autor:
Zsolt Piróth, Gábor Fülöp, Bettina Csanádi, Géza Fontos, Péter Andréka, Noémi Nyolczas, Jenő Szolnoky
Publikováno v:
Orvosi hetilap. 163(26)
A korábbi randomizált vizsgálatok rendre azt igazolták, hogy a coronariabypass-műtét előnyösebb a percutan coronariaintervencióval szemben a súlyos, kiterjedt koszorúér-betegség kezelésében. Ezt elsősorban az ismételt revascularisati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bfb1e93f6e86f3e65160cfca7e84ecd
https://pubmed.ncbi.nlm.nih.gov/35895484
https://pubmed.ncbi.nlm.nih.gov/35895484
Autor:
Noémi Nyolczas
Publikováno v:
Cardiologia Hungarica. 49:100-104
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d88f5ebdf57d66b3a1394962386c1b6
https://doi.org/10.26430/chungarica.2019.49.2.100
https://doi.org/10.26430/chungarica.2019.49.2.100